Robert Azelby - 13 Jun 2025 Form 4 Insider Report for ADC Therapeutics SA (ADCT)

Role
Director
Signature
/s/ Lisa Kallebo, as Attorney-in-Fact for Robert Azelby
Issuer symbol
ADCT
Transactions as of
13 Jun 2025
Net transactions value
-$45,108
Form type
4
Filing time
17 Jun 2025, 17:00:08 UTC
Previous filing
05 Jun 2025
Next filing
06 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Azelby Robert Director 430 MOUNTAIN AVENUE, SUITE 404, NEW PROVIDENCE /s/ Lisa Kallebo, as Attorney-in-Fact for Robert Azelby 17 Jun 2025 0001656998

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADCT Common Shares Tax liability $45,108 -12,600 -14% $3.58 80,405 13 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted.